http://chineseinput.net/에서 pinyin(병음)방식으로 중국어를 변환할 수 있습니다.
변환된 중국어를 복사하여 사용하시면 됩니다.
우황청심원의 고문헌기록 및 실험적 연구결과 분석을 통한 임상응용 확대의 필요성 고찰
오영택,오현묵,김서우,김원용,손창규,조정효,Oh, Young-Taeck,Oh, Hyeon-Muk,Kim, Seo-Woo,Kim, Won-Yong,Son, Chang-Gue,Cho, Jung-Hyo 대전대학교 한의학연구소 2017 혜화의학회지 Vol.26 No.1
Objectives: The aim of this study is (1) to investigate the historic changes and pharmacological efficacies of Woohwangchungsim-won and (2) to discuss the necessities for Woohwangchungsim-won's clinical applications. Methods: This study was performed through (1) investigating the ancient literature records related with Woohwangchungsim-won and analyzing Woohwangchungsim-won's composition, dosage and indications, (2) searching articles about Woohwangchungsim-won on 10 major Korean web and 3 major foreign web article search engines and analyzing Woohwangchungsim-won's pharmacological efficacies and indications. Results: Woohwangchungsim-wom has been used for cerebrovascular diseases such as stroke and palpitation. Also, there are some ancient literature records of Woohwangchungsim-won's clinical applications in neuropsychiatric disorders such as depression and bipolar disorder. In addition, there have been a number of experimental studies which demonstrate Woohwangchungsim-won's neuroprotective effect on cerebral cortex and hippocampus injury. So, it is possible to infer that Woohwangchungsim-won can be used for the treatments of neuropsychiatric disorders associated with neuronal cell death in cerebral cortex and hippocampus. But there have been no or less experimental studies which demonstrate the pharmacological efficacy of Woohwangchungsim-won on such disease. Conclusion: It is necessary that further experimental studies which demonstrate Woohwangchungsim-won's pharmacological efficacy on neuropsychiatric disorders should be done and Woohwangchungsim-won's clinical applications should be expanded on the basis of those related experimental results.
Ezetimibe decreased nonalcoholic fatty liver disease activity score but not hepatic steatosis
( Hyo Young Lee ),( Dae Won Jun ),( Hyun Jung Kim ),( Hyunwoo Oh ),( Waqar Khalid Saeed ),( Hyeongsik Ahn ),( Ramsey C. Cheung ),( Mindie H. Nguyen ) 대한내과학회 2019 The Korean Journal of Internal Medicine Vol.34 No.2
Background/Aims: A number of clinical trials reported varying effects of cho-lesterol lowering agents in nonalcoholic fatty liver disease (NAFLD) patients. We, therefore, assessed the changes in hepatic steatosis and NAFLD activity score (NAS) after treatment with cholesterol lowering agents in NAFLD patients by meta-analysis. Methods: The Cochrane Library, the MEDLINE, and the Embase databases were searched until May 2015, without any language restrictions, for randomized con-trolled trials (RCTs) and nonrandomized studies (NRSs). Additional references were obtained from review of bibliography of relevant articles. The quality of ev-idence was assessed using the grading of recommendations assessment, develop-ment and evaluation guidelines. Results: Three RCTs (n = 98) and two NRSs (n = 101) met our study inclusion cri-teria (adult, NAFLD, liver biopsy). Liver biopsy was performed in all five studies, but only the three studies reported NAS. Ezetimibe significantly decreased NAS (standardized mean difference [SMD], -0.30; 95% confidence interval [CI], -0.57 to -0.03) but not hepatic steatosis in RCT (SMD, -0.1; 95% CI, -0.53 to 0.32), while the effect was significant for both NAS and intrahepatic content in NRSs (SMD, -3.0; 95% CI, -6.9 to 0.91). Conclusions: Ezetimibe decreased NAS without improving hepatic steatosis.
Unexpected Restart Failure of Durable Left Ventricular Assist Devices: A Report of Two Cases
Hyo Won Seo,Ga Hee Jeong,Sung Min Kim,Minjung Bak,Darae Kim,Jin-Oh Choi,Kiick Sung,Yang Hyun Cho The Korean Society for Thoracic and Cardiovascular 2024 Journal of Chest Surgery (J Chest Surg) Vol.57 No.3
The HeartWare Ventricular Assist Device (HVAD) was widely used for mechanical circulatory support in patients with end-stage heart failure. However, there have been reports of a critical issue with HVAD pumps failing to restart, or experiencing delays in restarting, after being stopped. This case report describes 2 instances of HVAD failure-to-restart during heart transplantation surgery and routine outpatient care. Despite multiple attempts to restart the pump using various controllers and extensions, the HVAD failed to restart, triggering a hazard alarm for pump stoppage. In one case, the patient survived after receiving a heart transplantation, while in the other, the patient died immediately following the controller exchange. These cases highlight the rare but life-threatening complication of HVAD failure-to-restart, underscoring the importance of awareness among clinicians, patients, and caregivers, and adherence to the manufacturer's guidelines and recommendations for HVAD management.
Retrospective review & analysis of Intrauterine fetal death (IUFD)
( Hyo Sook Bae ),( Eun Joo Lee ),( Hye Ri Hong ),( Jae Won Kim ),( Geum Joon Cho ),( Soon Cheol Hong ),( Min Jung Oh ),( Hae Joong Kim ) 대한산부인과학회 2012 대한산부인과학회 학술대회 Vol.98 No.-
The purpose of this study was to analyze the characteristics of intrauterine fetal death and to elucidate some factors related to intrauterine fetal death. We did retrospective review the medical records of the 345 pregnancies with Intrauterine fetal death between January 2000 and December 2011. Also we statistically analyzed the data with regard to age, parity, BMI and sonographic findings. The age distribution of mother with IUFD was between 14 to 43 year old and was highest in the 30 to 34 year old age group (31.3%). The parity of mothers with IUFD was the highest in nulliparous group (182 cases, 52.8%). Multiparous group was consisted of 101 women with parity 1(29.3%), 48 women with parity 2 (13.9%) and 15 women with parity over three (4.3%). There were 166 cases (48.1%) with previous history of abortion. There were 22 cases (6.4%) with multiple pregnancy and 32 cases (32%) had anomaly. In subgroup with gestational age under 37 weeks, placentas are more likely to position at anterior uterine wall than posterior or lateral (p=0.001). We suggest that more attentions are required in pregnancy woman whose placenta is positioning anteriorly with gestational age over 37wks. The proper antenatal care should be taken to fetuses on the basis of risk factors of antepartum and intrapartum.
( Hyo Young Lee ),( Dae Won Jun ),( Hyunwoo Oh ),( Waqar Khalid Saeed ),( Jae Yoon Jeong ),( Joo Hyun Sohn ),( Chang Hong Lee ),( Hyun Jung Kim ),( Hyeong Sik Ahn ) 대한간학회 2016 춘·추계 학술대회 (KASL) Vol.2016 No.1
Aims: A number of clinical trials reported diverse effects of cholesterol- lowering agents in nonalcoholic fatty liver disease (NAFLD) patients. We, therefore, assessed the changes in non-alcoholic steatohepatitis activity score (NAS) and intrahepatic fat contents after treatment with cholesterol lowering agents in NAFLD patients by performing a meta-analysis. Methods: The Cochrane library, the MEDLINE, and the EMBASE databases were searched until June 2015, without any language restrictions, for randomized controlled trials (RCTs) and non-randomized studies (NRSs); additional references were obtained from reviewed articles. The quality of evidence was assessed using the grading of recommendations assessment, development and evaluation guidelines. Results: Three RCTs and three NRSs (235 participants) met the inclusion criteria for this updated systematic review. Liver biopsy was performed in three RCTs, but only the two studies reported NAS. Ezetimibe showed decreased NAS (Pooled RR: -0.65, 95% CI: -1.15 ~ -0.015). The intrahepatic fat contents were not decreased in RCTs, while they were decreased in NRSs. The baseline cholesterol level in all three RCTs was lower than the three NRSs (191mg/dl vs. 227.5mg/dl). The pre-planned secondary outcomes of AST, ALT, Glucose, HbA1c analysis did not show significant difference after treatment with cholesterol lowering agents. Conclusions: Ezetemibe decreased NAS score without improving intrahepatic fat contents.
Chronologic trends of cancer-related lymph node research in PubMed: informetrics analysis
Hyo-Jung Oh,Dongmin Yang,Hyo-Won Oh,Jae-Gyu Jeon,Chonghyuck Kim,Jeong-Yong Ahn,Se Wung Han,Chan-Young Kim 대한외과학회 2020 Annals of Surgical Treatment and Research(ASRT) Vol.99 No.5
Purpose: Given the long history of investigation into cancer and its relevance to the lymph node (LN), it would be meaningful to plot the trends of research on cancer-related LN. Methods: Queries such as “cancer,” “lymph node,” and “cancer and lymph node” were submitted to PubMed to collect articles on cancer and LN published between 1945 and 2017. The collected articles were then extracted by an automatic web crawler and examined through informetrics and linguistic analysis. Results: The number of articles related to cancer was 2,795,476 and 127,897 articles (4.6%) were found to be relevant to LN. With regard to cancer types, breast cancer was the most studied (37%), followed by gastric cancer (17%). With regard to the subjects in which the surgeon is interested, LN metastasis (57%) was found to be the topic most discussed, followed by LN dissection (22%) and sentinel LN (17%). Publications on LN metastasis gradually increased over time from 1988 to 2017 although those on sentinel LN and LN dissection have stagnated since the early 2000s. Conclusion: Although research on cancer was abundant, only a small portion was dedicated to investigating its relevance to LN. Western countries had led the research on cancer-related LN, but Asian countries began to participate as major players, expanding their contributions. While LN metastasis, one of the major cancer-related LN topics, showed a steady increase, those involved in oncologic surgery such as LN dissection and sentinel LN did not